Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Accenture (ACN.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-30338.46366.00Neutral
2022-06-23285.83302.00Neutral
2022-09-22262.32296.00Neutral
2023-03-23271.66300.00Neutral
2023-06-22307.25312.00Neutral
2023-09-28300.77333.00Neutral
2023-12-19341.51365.00Neutral
2024-01-24368.90400.00Neutral
2024-07-18328.10400.00Buy
2024-09-26355.81415.00Buy
2024-10-24364.23445.00Buy
2024-11-18352.79450.00Buy
2024-12-19372.16455.00Buy
2025-03-20300.91387.00Buy
2025-04-01313.58390.00Buy
2025-05-21317.72395.00Buy

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.